CD95-induced apoptosis in human liver disease

被引：118

作者：

Galle, PR

Krammer, PH

机构：

[1] Univ Heidelberg Hosp, Dept Internal Med, D-69115 Heidelberg, Germany

[2] German Canc Res Ctr, Tumorimmunol Program, D-6900 Heidelberg, Germany

来源：

SEMINARS IN LIVER DISEASE | 1998年 / 18卷 / 02期

关键词：

cytotoxic T cells; acute hepatic failure; viral hepatitis; alcoholic hepatitis; immune privilege;

D O I：

10.1055/s-2007-1007150

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

The CD95 receptor is a death receptor capable of transducing apoptotic cell death upon ligation with the CD95 ligand (CD95L). The CD95/CD95L system plays a physiological role in apoptosis of lymphocytes and liver cells. In addition, the striking finding of acute hepatic failure in mice upon CD95 triggering has stimulated general interest in the involvement of CD95 mediated apoptosis in human liver disease. The currently available data point to a deregulated CD95 system in viral hepatitis, alcoholic hepatitis, acute hepatic failure of different etiology, diseases of the bile ducts, and hepatocellular carcinoma. Animal experiments suggest a causative relationship between CD95 activation and liver cell death, which, however still has to be proven for liver disease in man. This review summarizes our present knowledge on CD95 mediated human liver disease.

引用

收藏

页码：141 / 151

页数：11

相关论文

共 90 条

[11] MDM2 EXPRESSION IS INDUCED BY WILD TYPE-P53 ACTIVITY [J].

BARAK, Y ;

JUVEN, T ;

HAFFNER, R ;

OREN, M .

EMBO JOURNAL, 1993, 12 (02) :461-468

[12] p53 in signaling checkpoint arrest or apoptosis [J].

Bates, S ;

Vousden, KH .

CURRENT OPINION IN GENETICS & DEVELOPMENT, 1996, 6 (01) :12-18

[13] A ROLE FOR CD95 LIGAND IN PREVENTING GRAFT-REJECTION [J].

BELLGRAU, D ;

GOLD, D ;

SELAWRY, H ;

MOORE, J ;

FRANZUSOFF, A ;

DUKE, RC .

NATURE, 1995, 377 (6550) :630-632

[14] CELL-AUTONOMOUS FAS (CD95) FAS-LIGAND INTERACTION MEDIATES ACTIVATION-INDUCED APOPTOSIS IN T-CELL HYBRIDOMAS [J].

BRUNNER, T ;

MOGIL, RJ ;

LAFACE, D ;

YOO, NJ ;

MAHBOUBI, A ;

ECHEVERRI, F ;

MARTIN, SJ ;

FORCE, WR ;

LYNCH, DH ;

WARE, CF ;

GREEN, DR .

NATURE, 1995, 373 (6513) :441-444

[15] INTERACTIONS BETWEEN P53 AND MDM2 IN A MAMMALIAN-CELL CYCLE CHECKPOINT PATHWAY [J].

CHEN, CY ;

OLINER, JD ;

ZHAN, QM ;

FORNACE, AJ ;

VOGELSTEIN, B ;

KASTAN, MB .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) :2684-2688

[16]

CHISARI FV, 1995, HEPATOLOGY, V22, P1316, DOI 10.1016/0270-9139(95)90645-2

[17] THYMOCYTE APOPTOSIS INDUCED BY P53-DEPENDENT AND INDEPENDENT PATHWAYS [J].

CLARKE, AR ;

PURDIE, CA ;

HARRISON, DJ ;

MORRIS, RG ;

BIRD, CC ;

HOOPER, ML ;

WYLLIE, AH .

NATURE, 1993, 362 (6423) :849-852

[18] AUTOCRINE T-CELL SUICIDE MEDIATED BY APO-1/(FAS/CD95) [J].

DHEIN, J ;

WALCZAK, H ;

BAUMLER, C ;

DEBATIN, KM ;

KRAMMER, PH .

NATURE, 1995, 373 (6513) :438-441

[19] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].

ELDEIRY, WS ;

TOKINO, T ;

VELCULESCU, VE ;

LEVY, DB ;

PARSONS, R ;

TRENT, JM ;

LIN, D ;

MERCER, WE ;

KINZLER, KW ;

VOGELSTEIN, B .

CELL, 1993, 75 (04) :817-825

[20] DOMINANT INTERFERING FAS GENE-MUTATIONS IMPAIR APOPTOSIS IN A HUMAN AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME [J].

FISHER, GH ;

ROSENBERG, FJ ;

STRAUS, SE ;

DALE, JK ;

MIDDELTON, LA ;

LIN, AY ;

STROBER, W ;

LENARDO, MJ ;

PUCK, JM .

CELL, 1995, 81 (06) :935-946

← 1 2 3 4 5 6 7 8 9 →